Source: International Congress 2018 – CC4 Tuberculosis
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Rendon (Monterrey, Mexico). Managing adult and children XDR-TB cases with limited clinical options. International Congress 2018 – CC4 Tuberculosis

Member's Comments

No comment yet.

Related content which might interest you: The clinical features and treatment of cases with MDR TB of adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 Poor treatment outcomes of XDR-TB patients in resource-limited settings Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan Source: ERJ Open Res, 8 (1) 00551-2021; 10.1183/23120541.00551-2021 Year: 2022 The experience of complex treatment of XDR-TB patients Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009 Challenges in TB treatment in children Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges Source: Eur Respir J 2016; 48: 938-943 Year: 2016 Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use Source: Eur Respir J, 50 (1) 1700311; 10.1183/13993003.00311-2017 Year: 2017 Identification and clinical management of LTBI in children versus adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Two major problems in TB patients today: MDR and the abandoned therapy Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011 DOTS-Plus treatment of MDR-TB patients with psychiatric disorders Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Non-tuberculous mycobacterial disease in patients who were referred as MDR-TB in resource limited settings: need for more rapid identification Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Challenges in TB treatment in adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 The clinical features and the risk factors of teenagers cases with MDR-TB in Romania Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Diagnosing and managing drug-resistant cases Source: Annual Congress 2009 - PG12 EU FP7 TB PAN-NET: Update in tuberculosis: advances in the management of drug resistant and multi-drug resistent tuberculosis cases Year: 2009 Impact of XDR-TB on treatment outcome of MDR-TB patients with standardized regimens Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Clinical management improves the treatment outcome of MDR-TB patients Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017 MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020